| Labatec Pharma SA - Atosiban Labatec 37.5 mg / 5 ml, solution à diluer pour perfusion |
| 69185 | | 02 | | Atosiban Labatec 37.5 mg / 5 ml | | solution à diluer pour perfusion | | G02CX01 | | Atosiban | | 04.03.2024 | | |
|
| Composition |
| atosibanum 37.5 mg ut atosibani acetas 39.8 mg, mannitolum, acidum hydrochloridum, natrii hydroxidum corresp. natrium 4.8 mg, aqua ad iniectabile q.s. ad solutionem pro 5 ml. |
| Packungsbestandteile |
| Concentrate for infusion | | | | | | Active Agent | Dose |
|---|
| Atosiban | 37.5mg / 5ml |
| | | | Inactive agents |
|---|
| Acidum Hydrochloridum | | Mannitol | | Sodium Hydroxide |
|
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 002 | | PR | PR | B | | No |
|
